Trials / Completed
CompletedNCT06134999
Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation
Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation. PRONES Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Las Palmas de Gran Canaria · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It will consist of a randomized clinical trial with a control group. The sample will be distributed as homogeneously as possible into two groups, which will be randomly divided into a control group, to which the usual general treatment will be applied, and an experimental group, which will be treated with the NESA XSignal device. During the procedure, the subjects will continue to receive the usual care routine.
Detailed description
The main objective will be to evaluate the efficacy of the NESA XSignal device in relation to the improvement of pain, functionality and quality of life in patients who have undergone total knee replacement surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Non-invasive Neuromodulation | The electrodes will be placed with the help of gloves and adapted socks for 1 hour, twice a week, until 10 intervention sessions are completed. In addition, depending on the session, an adhesive electrode will be placed at the level of C7. Characteristics of microcurrents: pulsed monophasic rectangular wave with a pulse of 1.3 s and pause of 300 ms, voltage 3 millivolt and intensity 0.5 μA. |
| DEVICE | Placebo Non-invasive Neuromodulation | The same protocol described for the experimental group will be applied, but microcurrents device which will be previously manipulated and tested with an oscilloscope so that they do not emit electrical currents. |
Timeline
- Start date
- 2023-11-11
- Primary completion
- 2025-05-13
- Completion
- 2025-07-31
- First posted
- 2023-11-18
- Last updated
- 2025-08-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06134999. Inclusion in this directory is not an endorsement.